Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Kristin Verbeke, Katholieke Universiteit Leuven
ClinicalTrials.gov Identifier:
NCT01666717
First received: August 14, 2012
Last updated: August 16, 2012
Last verified: August 2012
  Purpose

The purpose of the study is to evaluate fecal metabolites profiles of Inflammatory Bowel Disease(IBD) patients versus healthy controls (HC).


Condition
Inflammatory Bowel Diseases

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling

Resource links provided by NLM:


Further study details as provided by Katholieke Universiteit Leuven:

Biospecimen Retention:   Samples With DNA

Fecal samples


Enrollment: 204
Study Start Date: August 2008
Study Completion Date: May 2012
Groups/Cohorts
Healthy controls (HC)
HC
Inflammatory Bowel Disease (IBD) patients
Crohn's disease (CD), Ulcerative colitis (UC) and pouchitis

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Primary care clinic

Criteria

Inclusion Criteria:

  • Clinical diagnosis of IBD
  • Age >18 years

Exclusion Criteria:

  • Use of antibiotics in the preceding month
  • Intake of pre- or probiotics
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01666717

Locations
Belgium
KULeuven-UZLeuven
Leuven, Vlaams-Brabant, Belgium, 3000
Sponsors and Collaborators
Katholieke Universiteit Leuven
  More Information

No publications provided

Responsible Party: Kristin Verbeke, Professor K. Verbeke, Katholieke Universiteit Leuven
ClinicalTrials.gov Identifier: NCT01666717     History of Changes
Other Study ID Numbers: ML4355_VOC
Study First Received: August 14, 2012
Last Updated: August 16, 2012
Health Authority: Belgium: Ethics Committee

Additional relevant MeSH terms:
Inflammatory Bowel Diseases
Intestinal Diseases
Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases

ClinicalTrials.gov processed this record on April 17, 2014